Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

3 results
Display

Innovations in Clinical Research Design and Conduct in Psychiatry: Shifting to Pragmatic Approaches

Marks DM, Thanaseelan J, Pae CU

  • KMID: 2315808
  • Psychiatry Investig.
  • 2009 Mar;6(1):1-6.
The classically structured clinical trial does not offer enough flexibility to make use of continuously emerging knowledge that is generated as the trial progresses. In this regard, there are consistent...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Triple Reuptake Inhibitors: A Premise and Promise

Marks DM, Pae CU, Patkar AA

  • KMID: 2315789
  • Psychiatry Investig.
  • 2008 Sep;5(3):142-147.
On the horizon there is a new class of psychoactive medications which work by inhibiting the neuronal reuptake of serotonin, norepinephrine, and dopamine. There are multiple potential indications for these...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Does Pregabalin Have Neuropsychotropic Effects?: A Short Perspective

Marks DM, Patkar AA, Masand PS, Pae CU

  • KMID: 2315817
  • Psychiatry Investig.
  • 2009 Jun;6(2):55-58.
Pregabalin is a newly developed synthetic gamma-aminobutyric acid (GABA) that is approved for the treatment of fibromyalgia and several neuropathy. It has been proven to show analgesic, anxiolytic, anticonvulsant and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr